Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afamelanotide in mild to moderate acne vulgaris
NCT04943159Phase 2Completed
- Sponsor
- Clinuvel Pharmaceuticals
- Start
- Aug 2010
- Primary completion
- Mar 2011
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of Afamelanotide in acne vulgaris, sponsored by Clinuvel Pharmaceuticals. Started Aug 2010; status: completed.
02
Drugs
Afamelanotide
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04943159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04943159.